Li, Y., Li, M., Shats, I., Krahn, J. M., Flake, G. P., Umbach, D. M., . . . Li, L. (2019). Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma. PLoS One.

Li, Yuanyuan, Melissa Li, Igor Shats, Juno M. Krahn, Gordon P. Flake, David M. Umbach, Xiaoling Li, und Leping Li. "Glypican 6 Is a Putative Biomarker for Metastatic Progression of Cutaneous Melanoma." PLoS One 2019.

Li, Yuanyuan, et al. "Glypican 6 Is a Putative Biomarker for Metastatic Progression of Cutaneous Melanoma." PLoS One 2019.